New indication concerns the treatment of patients with relapsed or refractory mantle cell lymphoma
Αρχική World News EMA Recommends Extension of Indications for Acalabrutinib to Include the Treatment for...
New indication concerns the treatment of patients with relapsed or refractory mantle cell lymphoma